Dipna Pharmachem Board Approves Key Leadership and Committee Reconstitution
Dipna Pharmachem Ltd 路 Others (Uncategorized) 路 24 Oct 2026, 9:58 pm
Dipna Pharmachem Board Approves Key Leadership and Committee Reconstitution Dipna Pharmachem Limited announced that its Board of Directors approved the appointment of Mr. Nirav Madhusudan Soni as an Additional Non-Executive and Non-Independent Director, effective 10th Aug'26. Concurrently, Independent Directors Mr. Jitendra Pradipbhai Parmar and Mr. Manish Shrichand Bachani resigned due to personal reasons, with no other material reasons reported. Consequently, the company reconstituted its Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee, appointing Mr. Nirav Madhusudan Soni as Chairperson across all three key board committees.
Original exchange filing (PDF)
More announcements from Dipna Pharmachem Ltd
- Integrated Filing 路 04 Nov 2026
- Outcome of Board Meeting held today i.e. 4th November, 2026 路 04 Nov 2026
- Outcome of Board Meeting held today i.e. 4th November, 2026 路 04 Nov 2026
- Reconstitution of the Committee 路 04 Nov 2026
- Outcome and Intimation Under Regulation 30 of SEBI (LODR) Regulations, 2015 路 04 Nov 2026
- Outcome and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 04 Nov 2026
- Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) .... 路 01 Nov 2026
- Outcome and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 24 Oct 2026
